tiprankstipranks
Trending News
More News >
GeneDx Holdings (WGS)
NASDAQ:WGS
US Market

GeneDx Holdings (WGS) Financial Statements

Compare
879 Followers

GeneDx Holdings Financial Overview

GeneDx Holdings's market cap is currently $3.16B. The company's EPS TTM is $0.49; its P/E ratio is 1,792.37; GeneDx Holdings is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 305.45M$ 202.57M$ 234.69M$ 212.19M$ 179.32M
Gross Profit$ 194.40M$ 90.01M$ -26.75M$ -16.60M$ 4.03M
Operating Income$ -23.21M$ -180.60M$ -667.65M$ -446.15M$ -241.99M
EBITDA$ -1.26M$ -136.46M$ -398.20M$ -220.75M$ -227.13M
Net Income$ -52.29M$ -175.77M$ -548.98M$ -245.39M$ -241.34M
Balance Sheet
Cash & Short-Term Investments$ 141.19M$ 130.15M$ 137.40M$ 400.57M$ 108.13M
Total Assets$ 419.38M$ 418.76M$ 545.26M$ 554.09M$ 251.64M
Total Debt$ 116.17M$ 119.77M$ 77.13M$ 32.85M$ 43.26M
Net Debt$ 30.96M$ 20.09M$ -60.27M$ -367.72M$ -64.88M
Total Liabilities$ 174.13M$ 190.74M$ 291.56M$ 165.99M$ 247.25M
Stockholders' Equity$ 245.25M$ 228.02M$ 253.71M$ 388.10M$ 4.39M
Cash Flow
Free Cash Flow$ -33.99M$ -185.86M$ -333.48M$ -211.22M$ -125.10M
Operating Cash Flow$ -28.50M$ -180.15M$ -319.15M$ -190.43M$ -93.13M
Investing Cash Flow$ -30.13M$ -43.73M$ -141.33M$ -20.79M$ -31.97M
Financing Cash Flow$ 44.16M$ 186.24M$ 197.31M$ 493.73M$ 129.06M
Currency in USD

GeneDx Holdings Earnings and Revenue History

GeneDx Holdings Debt to Assets

GeneDx Holdings Cash Flow

GeneDx Holdings Forecast EPS vs Actual EPS